HLOSF
Price
$4.11
Change
-$0.34 (-7.64%)
Updated
Aug 18 closing price
Capitalization
423.46M
PCVX
Price
$33.03
Change
+$0.88 (+2.74%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
4.29B
65 days until earnings call
Interact to see
Advertisement

HLOSF vs PCVX

Header iconHLOSF vs PCVX Comparison
Open Charts HLOSF vs PCVXBanner chart's image
HEALIOS K K
Price$4.11
Change-$0.34 (-7.64%)
Volume$249
Capitalization423.46M
Vaxcyte
Price$33.03
Change+$0.88 (+2.74%)
Volume$26.69K
Capitalization4.29B
HLOSF vs PCVX Comparison Chart in %
Loading...
HLOSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HLOSF vs. PCVX commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLOSF is a Hold and PCVX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (HLOSF: $4.11 vs. PCVX: $33.02)
Brand notoriety: HLOSF and PCVX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HLOSF: 29% vs. PCVX: 103%
Market capitalization -- HLOSF: $423.46M vs. PCVX: $4.29B
HLOSF [@Biotechnology] is valued at $423.46M. PCVX’s [@Biotechnology] market capitalization is $4.29B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HLOSF’s FA Score shows that 0 FA rating(s) are green whilePCVX’s FA Score has 0 green FA rating(s).

  • HLOSF’s FA Score: 0 green, 5 red.
  • PCVX’s FA Score: 0 green, 5 red.
According to our system of comparison, PCVX is a better buy in the long-term than HLOSF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HLOSF’s TA Score shows that 3 TA indicator(s) are bullish while PCVX’s TA Score has 5 bullish TA indicator(s).

  • HLOSF’s TA Score: 3 bullish, 2 bearish.
  • PCVX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, HLOSF is a better buy in the short-term than PCVX.

Price Growth

HLOSF (@Biotechnology) experienced а 0.00% price change this week, while PCVX (@Biotechnology) price change was +7.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

PCVX is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PCVX($4.29B) has a higher market cap than HLOSF($423M). HLOSF YTD gains are higher at: 204.444 vs. PCVX (-60.726). PCVX has higher annual earnings (EBITDA): -584.35M vs. HLOSF (-2.39B). HLOSF has more cash in the bank: 6.25B vs. PCVX (1.66B). PCVX has less debt than HLOSF: PCVX (85.8M) vs HLOSF (2.61B). HLOSF has higher revenues than PCVX: HLOSF (112M) vs PCVX (0).
HLOSFPCVXHLOSF / PCVX
Capitalization423M4.29B10%
EBITDA-2.39B-584.35M409%
Gain YTD204.444-60.726-337%
P/E RatioN/AN/A-
Revenue112M0-
Total Cash6.25B1.66B376%
Total Debt2.61B85.8M3,036%
TECHNICAL ANALYSIS
Technical Analysis
HLOSFPCVX
RSI
ODDS (%)
Bearish Trend 2 days ago
20%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
29%
Bullish Trend 2 days ago
73%
MACD
ODDS (%)
Bearish Trend 2 days ago
27%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
15%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
12%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
N/A
Bearish Trend 11 days ago
79%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
67%
Aroon
ODDS (%)
Bullish Trend 2 days ago
48%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
HLOSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SNWCX61.331.32
+2.20%
Easterly Snow Small Cap Value C
IMIDX23.150.31
+1.36%
Congress Mid Cap Growth Institutional
TSEMX16.340.14
+0.86%
Touchstone Sands Cptl Emerg Mkts Gr Y
JAGTX72.480.61
+0.85%
Janus Henderson Glb Tech and Innovt T
EGLAX10.400.03
+0.29%
Eagle Energy Infrastructure A

HLOSF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLOSF has been loosely correlated with ORKA. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if HLOSF jumps, then ORKA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLOSF
1D Price
Change %
HLOSF100%
N/A
ORKA - HLOSF
62%
Loosely correlated
-3.04%
PCVX - HLOSF
39%
Loosely correlated
+0.16%
CYYNF - HLOSF
39%
Loosely correlated
N/A
FHTX - HLOSF
23%
Poorly correlated
+2.28%
DMAC - HLOSF
22%
Poorly correlated
+1.32%
More

PCVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PCVX has been loosely correlated with MIST. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if PCVX jumps, then MIST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCVX
1D Price
Change %
PCVX100%
+0.16%
MIST - PCVX
52%
Loosely correlated
N/A
ORKA - PCVX
45%
Loosely correlated
-3.04%
KYMR - PCVX
41%
Loosely correlated
-2.54%
DNLI - PCVX
40%
Loosely correlated
-3.40%
DYN - PCVX
40%
Loosely correlated
-1.78%
More